{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Gly",
          "alt": "Asp",
          "position": "309"
        },
        "variant_string_id": "PINK1 Gly309Asp"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations of the mitochondrial PTEN-induced kinase1 (PINK1) are important causes of recessive Parkinson disease (PD). The fundamental mechanism underlying these various phenotypes remains to be clarified. Using fruit fly and mouse models we show that PINK1 deficiency or clinical mutations impact on the function of Complex I of the mitochondrial respiratory chain, resulting in mitochondrial depolarization and increased sensitivity to apoptotic stress in mammalian cells and tissues.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to Complex I deficiency and mitochondrial dysfunction, which is relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The deficit in Complex I is functional and not directly reflecting significant alterations in assembly or expression of Complex I. We assessed ETC complexes in blue native polyacrylamide gel electrophoresis (BN-PAGE). Protein levels of different Complex I subunits and global assembly of Complex I, as well as of other ETC complexes, were not affected.",
          "judgment": "Yes",
          "reasoning": "The assay used effectively models the disease pathogenesis/mechanism by assessing the impact of PINK1 mutations on the function of Complex I, which is central to the molecular basis of PD as described.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Respiratory chain measurements performed on mitochondrial homogenates from Pink1 deficient fibroblast cell lines stably expressing human PINK1 (hPINK1res), PD-related PINK1 mutant hPINK1G309D and hPINK1W437X, and the artificial mutant hPINK1K219A. Spectrophotometric assays for Complex I activity (NADH:ubiquinone oxidoreductase, rotenone sensitive) were performed.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of spectrophotometric assays for Complex I activity, which is a standard and accepted method for assessing the function of this complex. The inclusion of both wild-type and mutant PINK1 expressing cells provides appropriate controls for the assay."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "In contrast, two PD PINK1 clinical mutations G309D (Gly309!Asp) and W437X (Trp437!Xxx) as well as an artificial mutation K219A (Lys219!Ala) that inactivates the kinase domain were not effective. Notably, expression of these PINK1 mutants did not alter the activity of the other ETC complexes.",
          "judgment": "Yes",
          "reasoning": "The functional assay data clearly show that the G309D mutation, along with other mutations, results in a significant reduction in Complex I activity, which is a key functional outcome supporting the pathogenicity of this variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The G309D variant in PINK1 results in a significant reduction in Complex I activity, as demonstrated by spectrophotometric assays. This functional defect is consistent with a pathogenic effect and aligns with the established role of Complex I dysfunction in PD, leading to the assignment of a 'PS3_very_strong' evidence strength for pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Trp",
          "alt": "Xxx",
          "position": "437"
        },
        "variant_string_id": "PINK1 Trp437Xxx"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations of the mitochondrial PTEN-induced kinase1 (PINK1) are important causes of recessive Parkinson disease (PD). The fundamental mechanism underlying these various phenotypes remains to be clarified. Using fruit fly and mouse models we show that PINK1 deficiency or clinical mutations impact on the function of Complex I of the mitochondrial respiratory chain, resulting in mitochondrial depolarization and increased sensitivity to apoptotic stress in mammalian cells and tissues.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to Complex I deficiency and mitochondrial dysfunction, which is relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The deficit in Complex I is functional and not directly reflecting significant alterations in assembly or expression of Complex I. We assessed ETC complexes in blue native polyacrylamide gel electrophoresis (BN-PAGE). Protein levels of different Complex I subunits and global assembly of Complex I, as well as of other ETC complexes, were not affected.",
          "judgment": "Yes",
          "reasoning": "The assay used effectively models the disease pathogenesis/mechanism by assessing the impact of PINK1 mutations on the function of Complex I, which is central to the molecular basis of PD as described.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Respiratory chain measurements performed on mitochondrial homogenates from Pink1 deficient fibroblast cell lines stably expressing human PINK1 (hPINK1res), PD-related PINK1 mutant hPINK1G309D and hPINK1W437X, and the artificial mutant hPINK1K219A. Spectrophotometric assays for Complex I activity (NADH:ubiquinone oxidoreductase, rotenone sensitive) were performed.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of spectrophotometric assays for Complex I activity, which is a standard and accepted method for assessing the function of this complex. The inclusion of both wild-type and mutant PINK1 expressing cells provides appropriate controls for the assay."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "In contrast, two PD PINK1 clinical mutations G309D (Gly309!Asp) and W437X (Trp437!Xxx) as well as an artificial mutation K219A (Lys219!Ala) that inactivates the kinase domain were not effective. Notably, expression of these PINK1 mutants did not alter the activity of the other ETC complexes.",
          "judgment": "Yes",
          "reasoning": "The functional assay data clearly show that the W437X mutation, along with other mutations, results in a significant reduction in Complex I activity, which is a key functional outcome supporting the pathogenicity of this variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The W437X variant in PINK1 results in a significant reduction in Complex I activity, as demonstrated by spectrophotometric assays. This functional defect is consistent with a pathogenic effect and aligns with the established role of Complex I dysfunction in PD, leading to the assignment of a 'PS3_very_strong' evidence strength for pathogenicity."
    }
  ]
}